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Introduction 
The basic premise of a stepped-wedge cluster randomised trial (SW-CRT) is that all clusters start in 
the control condition, and they switch to the intervention condition in an order determined by 
randomisation. SW-CRTs differ from cluster cross-over trials in that the switch is only in one 
direction, from control to intervention condition.  
An illustration of the design of one particular trial is shown in the Figure1. This design includes 10 
clusters which are randomised to five sequences (two clusters per sequence) which determine the 
order in which the clusters will receive the intervention. The steps are defined as the points when 
the intervention is delivered in each sequence (five steps in this case). Outcomes are measured in 
different periods (at six discrete time points in this case). The design can be generalised so that 
different numbers of clusters are randomised to each sequence and the periods between the steps 
do not have to be all the same length. There can be periods of time between measurement 
occasions to protect against carry-over of the intervention effect, as in a cross-over trial, or to allow 
the intervention to be delivered and exert its expected effects. SW-CRTs differ from a wait-list-
design in which clusters allocated to the control eventually receive the intervention but the outcome 
following the intervention does not contribute to the evaluation. Data obtained from the first and 
last measurement are sometimes omitted to reduce the duration of study without loss of power, as 
long as the cluster sizes are increased in compensation2. If a two-sequence design is restricted to the 
first two measurement occasions for sequences one and two, the design reduces to a cluster trial 
with baseline measurements.3 
SW-CRTs are typically regarded as falling into one of two broad types: cohort designs, where the 
same subjects are measured in each period; and cross-sectional designs where different subjects are 
measured in each period. Cohort trials can be closed, when there are no new recruits after the study 
is started, or open, when subjects may join the study after it has started 4 Outcomes can be 
measured at discrete points in time (for example using cross-sectional community surveys) or 
continuously in time (for example, when patients present to a hospital emergency department 
continuously over time and have their outcomes measured using routinely collected hospital data).5 
Rationale 
There are several reasons why a SW-CRT may be preferred over a parallel arm cluster trial,6,7 The 
SW-CRT may be more powerful than a parallel arm design; that is because within cluster 
comparisons can reduce the variance of the treatment effects.8 Another appealing reason is that 
policy makers may wish to roll out the intervention under a strong belief that it will be beneficial; in 
this case the adoption of a SW-CRT offers an opportunity for a rigorous evaluation of the 
intervention during routine implementation9. Some justify the use of the design citing ethical 
reasons for ensuring all of a population receive the intervention at some time10; although others 
have argued against this justification, since this corresponds to an a priori belief that the intervention 
is beneficial, which questions the need for a randomised evaluation7. However, in many SW trials 
there remains the possibility that the intervention may be either ineffective in a particular setting or 
that it may lead to harm, irrespective of an a priori belief in its benefits.7 There are other advantages 
to the use of a stepped wedge design, including enhanced ability to recruit. A justification that is 
sometimes used is that it may not be feasible to introduce the intervention to all clusters 
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simultaneously; however, this should not be the sole justification as the parallel arm cluster trial 
likewise can be conducted with a staggered roll-out.6 
Limitations 
Before adopting a SW-CRT it is important to weigh up the advantages and disadvantages of the 
design compared to a parallel arm cluster randomised trial (CRT). SW-CRTs can be logistically more 
complicated and there are more decisions to make such as the timing of the intervention and the 
length of the steps. Crucially, since clusters are randomised as to the time of implementing the 
intervention, all cluster approvals must be in place before the study can start. The design is also 
vulnerable to drop-out or under recruitment at either the cluster or patient level, as the addition of 
non-randomized clusters once the trial has started is questionable and extending the duration of the 
study to recuperate any loss in recruitment might have negligible benefits in terms of power. While 
the SW-CRT may require fewer clusters than a parallel arm CRT (depending on the cluster size, intra-
cluster correlation coefficient (ICC) and number of measurement periods), it may require a larger 
number of subjects and/or measurements, and impose a higher burden on patients, which in cohort 
studies8 may lead to patients dropping out and reducing the power of the study. A SW-CRT may take 
longer to complete, particularly if the treatment effect takes a long time to exert its effect.  Perhaps 
the most important limitation of the design is the inducement of confounding by time: the SW-CRT 
must always adjust for time because of this confounding. 
Examples 
The Devon Active Villages (DAVE) trial is an example of a cross-sectional SW-CRT11. Here 128 rural 
villages (clusters) were randomised to one of four sequences. The intervention was tailored to each 
village and provided 12 weeks of physical activity opportunities, including at least three different 
types of activities per village. Support was provided for a further 12 months. Each measurement 
occasion was separated by several months to avoid the peak holiday periods. A random sample of 
households within each village was selected to receive a postal survey at baseline (in the month 
prior to commencement of the first intervention period) and within a week of the end of each of the 
four intervention periods. The primary outcome of interest was the proportion of adults reporting 
sufficient physical activity to meet internationally recognised guidelines. Thus each household is only 
likely to appear once in the trial. Because of the staggered nature of the intervention, the trial was 
spread over nearly two years, whereas a conventional parallel group trial might have been 
conducted over a shorter duration. 
An example of a cohort design is a trial of a resistance training programme on physical function in 
patients receiving dialysis.12 A total of 171 patients from 15 community satellite haemodialysis clinics 
participated in the evaluation of a progressive resistance training programme which used resistance 
elastic bands in patients in a seated position during the first hour of haemodialysis treatment. The 
stepped-wedge design had three sequences, each containing five randomly allocated clinics which 
switched to the intervention at 12, 24 or 36 weeks. The primary outcome was an objective physical 
function measurement, taken at the end of each 12 week period up to 48 weeks. Including the 
baseline measurement, 113 patients were measured five times. Essentially this is a closed cohort 
design, since no new patients were recruited after study start. However there was considerable 
drop-out during the trial and a careful statistical analysis was required to account for this. 
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Design and Analysis 
The standard method of analysis uses a mixed-effects model, frequently referred to as the Hussey 
and Hughes model, which includes random effects for the clusters and fixed effects for the time 
periods13. However, methodology for the SW-CRT design has developed substantially in recent years 
with new analytical models being proposed to allow for more flexible correlation structures.14 
Additional methodological complexities in SW-CRTs include the possibility of within cluster 
contamination over time and time varying treatment effects. SW-CRTs require more complex 
approaches to both sample size determination and analysis14.  For example, additional random 
effects, for cluster-periods or for repeated measures on the same participants may be required to 
allow correlations to depend on time of measurement.  
There are now computer programs (for example in Stata) to aid in the sample size calculation for a 
SW-CRT8. To adjust for clustering, sample size calculations require not only an estimate for the intra-
cluster correlation coefficient, as for a conventional cluster trial, but also an estimate for the 
correlation between measurements over time, in addition to the usual parameters such as the effect 
size.  Cohort designs require additional correlation coefficients. Often advance estimates for these 
correlations are difficult to obtain and sample size calculations therefore should incorporate 
sensitivity analyses to examine implications of a range of values for the correlation coefficients.  
Unsurprisingly, given their complexities, reviews have shown that SW-CRTs are often poorly 
designed and analysed.1,15. There is now a CONSORT extension to SW-CRTs which is designed to 
improve the reporting of these trials.2 Investigators planning a SW-CRT are advised to study the 
CONSORT extension to SW-CRTs, to ensure that all relevant aspects required in the reporting of the 
completed trial are considered in advance and not just during the write-up when it would be 
impossible to change the design and the relevant information may not be available. Many of the 
issues discussed here are covered in more detail in this elaboration paper. 
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Figure: The Stepped wedge design The shaded area is when the intervention is applied: Figure from 
ĂƌŬĞƌ ?DĐůĚƵĨĨ ? ?ƐƚĞ ?ĂŵƉďĞůů1 (with permission) 
 
